Ribociclib and Bicalutamide in AR+ TNBC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Novartis
Related studies linked through entity extraction aliases.
Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
The Development, Implementation and Evaluation of Clinical Pathways for Chronic Obstructive Pulmonary Disease (COPD) in Saskatchewan
- Status
- UNKNOWN
- Phase
- N/A
A Study of LEE011 With Everolimus in Patients With Advanced Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2
LEE011 Plus Everolimus in Patients With Metastatic Pancreatic Adenocarcinoma Refractory to Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Trial of IDH305 in IDH1 Mutant Grade II or III Glioma
- Status
- WITHDRAWN
- Phase
- PHASE2
Intraocular Cytokine in Recurrence of Polypoidal Choroidal Vasculopathy
- Status
- UNKNOWN
- Phase
- PHASE4
Concurrent Dabrafenib + Trametinib With Sterotactic Radiation in BRAF Mutation-Positive Malignant Melanoma and Brain Metastases
- Status
- TERMINATED
- Phase
- PHASE2
Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
The Drug Rediscovery Protocol (DRUP Trial)
- Status
- RECRUITING
- Phase
- PHASE2
Intravitreal Ranibizumab (Lucentis®) for Neovascular Glaucoma- a Randomized Controlled Study
- Status
- UNKNOWN
- Phase
- PHASE3
Ruxolitinib Combined With Ibrutinib in Chronic Lymphocytic Leukemia Patients
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Efficacy and Safety of Nilotinib in Patients With a Chronic Disease of the Graft Against the Host
- Status
- COMPLETED
- Phase
- PHASE2
Trametinib in Treating Patients With Progressive Metastatic Hormone-Resistant Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Association of FcγRIIIA Polymorphism and THPO Expression With Response to Eltrombopag in Refractory ITP Patients
- Status
- UNKNOWN
- Phase
- PHASE3
Investigating Patient Satisfaction With Oral Anti-cancer Treatment in Patients With Hormone-receptor Positive, HER2-receptor Negative, Advanced Breast Cancer
- Status
- UNKNOWN
- Phase
- N/A
Comparison of PDT Combination With Ranibizumab vs. Ranibizumab Monotherapy in Persistent PCV With Initial Loading Dose
- Status
- UNKNOWN
- Phase
- PHASE4
Neoadjuvant Dabrafenib, Trametinib and/or Pembrolizumab in BRAF Mutant Resectable Stage III Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
Effect of Secukinumab in the Treatment of Psoriatic Arthritis
- Status
- COMPLETED
- Phase
- PHASE2
Functional and Structural Outcomes in Neovascular Age-related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE4